MedPath

Effect of intravenous vitamin c in decreasing ferritin level in patients with ESRD under dialysis

Phase 3
Conditions
Chronic kidney disease (CKD).
Anemia in chronic kidney disease
D63.1
Registration Number
IRCT20191112045426N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
32
Inclusion Criteria

Patients undergoing hemodialysis with iron deficiency anemia with Hb <11 g / dl and serum ferritin level (> 500 ng / ml) and transferrin saturation (TSAT = 20%)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Age. Timepoint: before intervention. Method of measurement: Form.;Gender. Timepoint: before intervention. Method of measurement: Form.;Marital status. Timepoint: before intervention. Method of measurement: Form.;Serum ferritin level. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Hemoglobin. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;TIBC(Total Iron binding capacity ). Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Transferrin saturation. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Intervention group. Timepoint: before intervention and after three months. Method of measurement: software.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath